Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pure Derma is a UK-based medical aesthetic company specializing in the development and distribution of advanced skincare and body contouring technologies. The company is best known for its PureDerma platform, which utilizes fractional radiofrequency (RF) microneedling to treat various skin concerns such as wrinkles, scarring, and skin laxity. In addition to its flagship microneedling device, Pure Derma offers a range of other aesthetic systems including the PureHydro facial platform and PureLift body contouring devices. The company provides comprehensive training and support to clinical practitioners, positioning itself as a key player in the non-surgical aesthetic market. Pure Derma's technologies are designed to provide minimally invasive alternatives to traditional surgical procedures, focusing on safety and efficacy in skin rejuvenation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pure Derma.